NanoViricides financial statements

Name: Quantus Signal — KR/US technical signal dataset
License: https://www.quantus.kr/signal/terms

나노바이리사이드스NYSEAMERICAN:NNVC · NYSE Amex · Healthcare

$1.28+1.59%

2026-10-02 close

NanoViricides's published financial data is dated 2026-10-04. 2025 revenue was $0M. 2025 operating profit was −$10M.

Reported results

Quantus Signal · live data · not investment advice · Privacy Policy